Trials / Withdrawn
WithdrawnNCT02169193
Diagnosis of Microaspiration in Intubated Critically Ill Patients: Pepsin vs 99m Technetium
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Microaspiration of contaminated oropharyngeal secretions and gastric contents frequently occurs in intubated critically ill patients, and plays a major role in the pathogenesis of ventilator-associated pneumonia. Quantitative pepsin measurement in tracheal aspirates would be useful in diagnosing microaspiration of gastric contents in intubated critically ill patients. Technetium 99m labelled enteral feeding is the gold standard for the diagnosis of microaspiration. The investigators hypothesized that tracheal pepsin measurement is a good diagnosis marker of microaspiration compared to the gold standard.
Detailed description
Microaspiration of contaminated oropharyngeal secretions and gastric contents frequently occurs in intubated critically ill patients, and plays a major role in the pathogenesis of ventilator-associated pneumonia Quantitative pepsin measurement in tracheal aspirates would be useful in diagnosing microaspiration of gastric contents in intubated critically ill patients Technetium 99m labelled enteral feeding is the gold standard for the diagnosis of microaspiration. We hypothesized that tracheal pepsin measurement is a good diagnosis marker of microaspiration compared to the gold standard
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | 99mTc-Rhenium Sulfide Nanocolloid | 12 MBq of NanoCis added to 500 ml of enteral feeding |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-09-01
- Completion
- 2017-01-01
- First posted
- 2014-06-23
- Last updated
- 2015-12-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02169193. Inclusion in this directory is not an endorsement.